Zobrazeno 1 - 10 of 21 pro vyhledávání: '"Erika Szabo"'
1
Akademický článek
Real-world evidence study on the impact of SPECT MPI, PET MPI, cCTA and stress echocardiography on downstream healthcare utilisation in patients with coronary artery disease in the US
Autor: Matthieu Pelletier-Galarneau, Arturo Cabra, Erika Szabo, Santosh Angadageri
Publikováno v: BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-12 (2024)
Abstract Background Coronary artery disease (CAD) is associated with a large clinical and economic burden. However, consensus on the optimal approach to CAD diagnosis is lacking. This study sought to compare downstream healthcare resource utilisation
Externí odkaz: https://doaj.org/article/f025a5cb044547f3812b9aef62d6259a
Zobrazit plný text záznamu
2
Real-world healthcare resource utilization in patients with indolent non-Hodgkin lymphoma: differences between patients treated with first-line ibrutinib or bendamustine + rituximab
Autor: Gerard Hoehn, Debra E. Irwin, Kathleen Wilson, Erika Szabo, Stella Min
Publikováno v: Current Medical Research and Opinion. 36:439-444
Objective: This study evaluated the real-world healthcare resource utilization (HCRU) and costs in patients diagnosed with an indolent non-Hodgkin lymphoma (iNHL) and treated with either first-line...
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2168c5c6d8fc80a3c66c51f1b5e511ed
https://doi.org/10.1080/03007995.2020.1713074
Zobrazit plný text záznamu
4
Meta-analysis and indirect treatment comparison of lipegfilgrastim with pegfilgrastim and filgrastim for the reduction of chemotherapy-induced neutropenia-related events
Autor: Omar Tomey, Lee Schwartzberg, Udo Mueller, T Christopher Bond, Boxiong Tang, Susan Gabriel, Erika Szabo, Jean Klastersky
Publikováno v: Journal of oncology pharmacy practice, 24 (6
Journal of Oncology Pharmacy Practice
Background: Granulocyte colony-stimulating factors are effective at reducing the risk and duration of neutropenia. The current meta-analysis compared the neutropenia-related efficacy and safety of lipegfilgrastim to those of pegfilgrastim and filgras
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdf59780b61929dacef08da8bc9ede2f
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/280444
Zobrazit plný text záznamu
5
Patient-Administered Biologic and Biosimilar Filgrastim May Offer More Affordable Options for Patients with Nonmyeloid Malignancies Receiving Chemotherapy in the United States: A Budget Impact Analysis from the Payer Perspective
Autor: Erika Szabo, Holly Trautman, Boxiong Tang, Elizabeth James
Publikováno v: Journal of managed carespecialty pharmacy. 25(1)
Granulocyte colony-stimulating factors (G-CSFs) are often administered to reduce the incidence, severity, and duration of febrile neutropenia (FN) in chemotherapy patients. Tbo-filgrastim and filgrastim-sndz represent a follow-on biologic and a biosi
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bd97a92acca24627938d66a5522e840
https://pubmed.ncbi.nlm.nih.gov/30084301
Zobrazit plný text záznamu
7
Assessing the Need for a Biosimilar: A Systematic Literature Review of the Treatment Burden of Rituximab in Hematological Malignancies
Autor: Elizabeth James, Erika Szabo, Gerard Hoehn, Boxiong Tang, Holly Trautman
Publikováno v: Blood. 132:5908-5908
BACKGROUND: Advanced targeted therapies have improved survivals and efficacies in patients with certain hematology conditions. However, the treatment costs and safety are some concerns among healthcare providers, patients, and payers. OBJECTIVES: To
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::1ab32e372d5528e5afc4548e08e46a67
https://doi.org/10.1182/blood-2018-99-110953
Zobrazit plný text záznamu
8
Real-World Healthcare Resource Utilization in Patients with Chronic Lymphocytic Lymphoma: Differences between Patients Treated with Ibrutinib or Bendamustine + Rituximab
Autor: Kathleen Wilson, Gerard Hoehn, Debra E. Irwin, Lu Zhang, Erika Szabo, Boxiong Tang
Publikováno v: Blood. 132:3548-3548
OBJECTIVES: The purpose of this study was to examine the real-world differences in healthcare resource utilization in chronic lymphocytic lymphoma (CLL) patients treated with either first-line ibrutinib monotherapy (IM) or first-line bendamustine + r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::b7c27d65799c5deda36118f4ea6051d6
https://doi.org/10.1182/blood-2018-99-112626
Zobrazit plný text záznamu
9
Paleomagnetic and geochemical evidence for a pre-Triassic age for the Lower Amaranth Member of the Williston Basin of Manitoba (Canada)
Autor: Erika Szabo, Ihsan S. Al-Aasm, M. T. Cioppa
Publikováno v: Canadian Journal of Earth Sciences. 46:855-873
Paleomagnetic and geochemical data obtained from six wells in southwestern Manitoba indicate that the Lower Amaranth redbeds were deposited earlier than Jurassic or Triassic, the most commonly cited depositional ages for this formation in the Willist
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::457d71d5319c9758527f6e18b5eb31ef
https://doi.org/10.1139/e09-058
Zobrazit plný text záznamu
10
Multiple magnetization events in the Red River carbonates, Williston Basin, Canada: Evidence for fluid-flow?
Autor: Erika Szabo, M. T. Cioppa
Publikováno v: Journal of Geochemical Exploration. 89:384-388
Samples collected from the Upper Ordovician Red River carbonates in a well at the centre of the Williston Basin revealed two paleomagnetic components with different inclinations, 60.3 ± 3.9° (k = 70.7, N = 12) and 20.4 ± 3.3° (k = 141.2, N = 8),
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d0e9173413aeedff9fe0b5b25b32ffe
https://doi.org/10.1016/j.gexplo.2005.12.007
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje